NT
Neela Therapeutics, Inc.
SEC filingOther Health Care · Lunenburg, MA
Amount raised$13.8Msold at filing
Total offering$21.5M$7.7M still open
Investors in the raise21count reported to the SEC
FiledMay 26, 2026first sale Nov 14, 2025
Form D does not name the investors. If a news report names them, they appear here.
Named in the filing
Richard UptonDirector
Edgar D. Jannotta Jr.Director
Norbert RiedelDirector
David DonabedianDirector
PJ AnandExecutive Officer, Director
Stephen D. OesterleDirector
Executive officers, directors and promoters as listed on the Form D.